Researchers from Massachusetts and West Virginia have developed a wireless ingestible device called the Vitals Monitoring Pill (VM Pill) for remote monitoring of vital signs. The capsule-sized device utilizes integrated circuits and electronic sensors, including an accelerometer, to accurately measure respiratory and heart rates based on small ballistic movements in the gastrointestinal tract. In preclinical animal studies, the device detected signs of opioid-induced respiratory depression. A human trial involving 10 patients in a sleep study demonstrated that the VM Pill collected comparable respiratory and heart rate data to existing monitoring devices. Future plans include extending the device’s duration in the stomach and creating closed-loop systems for detecting and responding to life-threatening events, such as opioid overdoses. This development showcases the potential of ingestible vital monitors in rapidly responding to critical situations.

Article written by Anuja Vaidya| Image by Stat News



MHealth News